Evaluation of low-dose cytarabine therapy in myelodysplastic syndromes.
Original article English el Mangoush M, Singh MK, Kumar S, Korajkio M, Gamati A. Medicine Dpt., Hawari Hospital, Arab Medical University, Benghazi, Libya. Bone Marrow Transplant. 1989 Dec;4 Suppl 3:100. Abstract Myelodysplastic syndromes (MDS) are a group of disorders characterised by progressive cytopenias and impaired maturation of haematopoietic cells. It carries a high mortality due …
Evaluation of low-dose cytarabine therapy in myelodysplastic syndromes. Read More »